With its devel­op­ment pro­ject GO-Immun for the treat­ment of autoim­mune dis­eases, ISAR Bioscience has once again been able to con­vince a renowned fund­ing agency.

The Bav­arian research com­pany ISAR Bioscience is well on the way to a new Alzheimer’s therapy.

ISAR Bioscience has been gran­ted a man­u­fac­tur­ing author­isa­tion in accord­ance with the Ger­man Medi­cines Act (§13 AMG) and a GMP (Good Man­u­fac­tur­ing Prac­tice) cer­ti­fic­a­tion for its facil­ity in Planegg near Munich.

In the cooper­a­tion pro­ject with the Uni­ver­sity of Munich, cell cul­ture mod­els will be cre­ated for the devel­op­ment of novel drug therapies.